We are experiencing extremely high demand in our Emergency Department.Learn more.
Masking and Visitation Changes: Due to high rates of respiratory illnesses in our community, we’ve made changes to our masking and visitation guidelines. Learn more.
Antibody secreting plasma cells are dedicated protein-producing machines that are responsible for neutralizing viruses and bacteria, but also can cause disease. We study the proteins and genes responsible for differentiation of and/or long-lived survival of antibody-secreting cells.
Engineering B Cells to Produce Therapeutic Proteins
Historically, gene delivery to B cells has been challenging. We recently developed an efficient method for gene delivery to primary human B cells. One focus of the lab is to leverage this technology to build a cell therapy for protein delivery.
B Cell-Based Protein Delivery Could be a Lifelong Cure
Antibody-secreting B cells exhibit two features that we think can be translated into a long-term treatment. First, these cells can produce protein indefinitely. Second, antibody-secreting B cells produce similar quantities of protein as industrial cell lines.
Our lab is currently focused on (1) identifying optimal conditions for differentiation of engineered human B cells into long-lived antibody-secreting cells, (2) assessing the impact of autophagy on plasma cell survival, and (3) determining the effect that a host immune system will have on engrafted engineered B cells.
By clicking “Accept All Cookies,” you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in marketing efforts. For more information, see Website Privacy.